Neuronetics, Inc. (STIM)
Treats severe depression using magnetic pulses to stimulate the brain in doctors' offices.
$1.87+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-57.7%
The outlook
STIM is trading near $1.87 with strong analyst backing—the consensus leans "Strong Buy" with an average price target about 141% above the current level. The stock sits well above its 50- and 200-day moving averages and trades in the lower quarter of its 52-week range, suggesting it's recovered from recent lows but remains far below recent highs.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 4 analysts
Price trendAbove its 50- & 200-day averages
52-week range26% of the way from its 52-week low to high
Price targetAvg target +141% vs current price
Analyst price target
~12-month · 4 analysts$4.50average target+140.6% vs now
Now $1.87
Low $3.00High $7.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$130.1M
52-wk high
$4.85
52-wk low
$0.80
50-day avg
$1.46
200-day avg
$1.68
Trailing P/E
—